EOS Iamging

Paris, France Founded: 1989 • Age: 37 yrs Listed Acquired By ATEC Spine
2D3D orthopedic imaging systems and software solutions are developed.

About EOS Iamging

EOS Iamging is a Healthcare company based in Paris (France) founded in 1989, and was acquired by ATEC Spine in February 2020. It operates as a 2D3D orthopedic imaging systems and software solutions are developed. EOS Iamging has raised $43.8 million across 5 funding rounds from investors including Crédit Agricole, ATEC Spine and Fosun Pharmaceutical. EOS Iamging offers products and services including EOSedge, Advanced Orthopedic Solutions, and 3D Modeling. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Screening Devices. Its legal entity is EOS IMAGING. Its competitors include OXOS Medical, Scolioscan, Emerge Diagnostics, Aclarion and Knee Voice and 4 more; 6 of its 9 listed competitors have raised funding.

Company details

Founded in 1989 and based in Paris, France, the company operates in the medical imaging sector. 2D3D orthopedic imaging systems are provided to generate precise skeletal images of patients in upright positions, with reduced radiation exposure. Software solutions are developed to support various aspects of orthopedic care, including diagnostics and treatment planning, for healthcare professionals worldwide.

  • Headquarters Paris, France
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website eos-imaging.com
  • Social LinkedIn X Facebook Instagram
  • Acquired by ATEC Spine (Feb 2020)
  • Legal Name Eos Imaging
Operational Areas
Key Metrics
  • Total Equity Funding
    $43.8M (USD)

    in 5 rounds

  • Latest Funding Round
    $17.07M (USD), Post-IPO

    Jul 2018

  • Investors
  • Acquired by
    ATEC Spine

    (Feb 2020)

Products & Services of EOS Iamging

EOS Iamging offers a comprehensive portfolio of products and services, including EOSedge, Advanced Orthopedic Solutions, and 3D Modeling.

EOSedge
Imaging Solution

Provides advanced low-dose 2D/3D imaging for orthopedic applications

Advanced Orthopedic Solutions
Software Platform

Offers tools for 3D measurements and surgical planning

3D Modeling
Diagnostic Tool

Generates accurate 3D models from medical images for analysis

Funding Insights of EOS Iamging

EOS Iamging has successfully raised a total of $43.8M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $17.07 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $43.8M
  • Total Rounds 5
  • Last Round Post-IPO — $17.07M
  • First Round $8.85M

    (Jun 2005)

  • Investors Count 9

All 5 funding rounds of EOS Iamging with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2018$17.07MPost-IPO––
Jan 2015$17.71MDebt – Conventional––
Apr 2010$16.71MPrivate Equity Round–CDC Enterprises
Nov 2007$18.24MPrivate Equity Round–NBGI Ventures, Credit Agricole
Jun 2005$8.85MPrivate Equity Round–Edmond de Rothschild, Business Angel
–
Valuation history

10 investors in total: 10 institutional.

Investors in EOS Iamging

EOS Iamging has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Crédit Agricole, ATEC Spine and Fosun Pharmaceutical.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Alternative financing is provided by IPF Partners for healthcare.
–ipfpartners.comLuxembourg, Luxembourg
Diversified asset management, corporate advisory, and private equity firm focused on multiple sectors
1953edmond-de-rothschild.comParis, France
-
–ufg-pe.com-
Private equity firm focused on energy transition and sustainable investments across Europe.
–omnescapital.com-
-
–nbgiventures.com-
Research, development, production, and sale of pharmaceuticals are provided.
1994fosunpharma.comShanghai, China
B2B portal for client imports, product management, and user account handling.
1988cdcentreprises.frParis, France
Crédit Agricole is recognized as a leading banking institution in France.
1894credit-agricole.comMontrouge, France
Gildo is engaged in electric vehicle manufacturing and sales.
–business-angel.comMonaco, Monaco
Treatment solutions for spine disorders are developed.
1990atecspine.comSan Diego, United States
Premium access

Investor details for EOS Iamging

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of EOS Iamging

31 people are tracked at EOS Iamging (10 in leadership, 21 in team).

NameRoleGroup
Bernard Ismael
Director Of Quality & Regulatory AffairsLeadership
Dave Sponsel
Executive Vice President, SalesLeadership
Ali Shorooghi
Senior Vice President, MarketingLeadership
Scott Lish
Senior Vice President, Research And DevelopmentLeadership
Mathieu Garayt
Director, EOS MarketingLeadership
Todd Koning
Chief Financial OfficerLeadership
Eric Dasso
Executive Vice PresidentLeadership
Tyson Marshall
Vice President And Associate General CounselLeadership
Pat Miles
Chairman, Chief Executive OfficerLeadership
Hélène Roty
Chief People OfficerLeadership
Justine Romero
Software EngineerTeam
Pauline Pervier
Ingénieure Assurance Qualité OpérationnelleTeam
Yannick Guillemot
EOS Software Development ManagerTeam
Delphine Fontaine-Lebrun
Medical WriterTeam
Sophie Demeulemeester
Développeuse Back-endTeam
Sébastien Guessard
3d Modeling Programs ManagerTeam
Anais Loloum
Chargée De Marketing - VenteTeam
Cyprien Vallette
Ingénieur Développement WebTeam
Albert Nonga
Human Resources GeneralistTeam
Benjamin Aubert
Senior Data Scientist And Partnership LeadTeam

11 more people are available in the full profile.

Premium access

Complete people profiles for EOS Iamging

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of EOS Iamging

5 dated milestones of EOS Iamging across 31 years, from founding to its latest funding, stage changes and deals.

  1. Founded EOS Iamging is founded.
  2. Funding First funding round of $8.8M.
  3. IPO Lists on the stock exchange (IPO).
  4. Funding Latest funding round, Post-IPO, of $17.1M.
  5. Exit Acquired by ATEC Spine.

Competitors of EOS Iamging

EOS Iamging has 9 listed competitors in our database, 6 of them funded. They include OXOS Medical, Scolioscan, Emerge Diagnostics, Aclarion and Knee Voice, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
oxos.com2001Atlanta, United States$42.46M–
Orthopedic imaging devices and software are developed for surgical use.
scolioscan.com2012Hong Kong, China$5.52M–
Radiation-free 3D ultrasound scoliosis assessment is developed.
emergedx.com2012Carlsbad, United States$6.74M–
Soft tissue injuries are diagnosed via a specialized electrodiagnostic device.
aclarion.com2008Broomfield, United States$3.26M6
SaaS-based radiology image analysis tools are provided for medical providers.
kneevoice.com2015Santa Monica, United States$1.87M7
Knee health is monitored via a wearable device during activities.
forethoughtmed.com2023China––
Solutions for spinal health measurement and examination are provided.
dsmedco.com2012Poway, United States$11.52M–
Acoustic coherent tomography imaging systems are provided for medical diagnostics.
kneedly.se2021Gothenburg, Sweden––
Knee ligament injuries are diagnosed by software for healthcare professionals.
maknee.fi2017Oulu, Finland––
It serves as a limited information available.
Premium access

Detailed competitors of EOS Iamging

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of EOS Iamging

The website of EOS Iamging (eos-imaging.com) receives about 7K visits a month.

  • Monthly visits
    7K

    ▲ 14.6% vs previous month

Similar websites

Websites whose visitors overlap most with EOS Iamging. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
atecspine.com
100%
80.3K#698,709View details
laradiologie.com
laradiologie.com
75%
–#1,263,742–
dotmed.com
75%
–#118,835View details
em-consulte.com
em-consulte.com
75%
–#109,284–
nice.org.uk
75%
5M#14,452View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 13 similar websites and full traffic analytics for EOS Iamging

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Orthopedics

10 companies that operate in the same segment as EOS Iamging (Orthopedics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Prosthetic and orthotic devices are developed for individuals with disabilities.
1919Duderstadt, Lower Saxony, GermanyUSD 17 MUSD 1.97 B–
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Developer of drugs for treating rare and autoimmune diseases
2008Dublin, IrelandUSD 61.78 MUSD 617.41 M–
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M––
Robotic arms are provided for mobility and rehabilitation support.
2004Boston, Massachusetts, United StatesUSD 17.21 MUSD 40.93 M185
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608 M––
Exoskeletons for medical rehabilitation and industrial productivity are provided.
2005United StatesUSD 24.37 MUSD 71.6 M61
Stabilization devices for healthcare are manufactured by the company.
2005New York, New York, United StatesUSD 142.15 M–43
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Eos Iamging

Premium access

Complete news archive for EOS Iamging

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about EOS Iamging

EOS Iamging was founded in 1989 and raised its 1st funding round 16 years after it was founded.

EOS Iamging is headquartered in Paris, France.

EOS Iamging is a funded company, having raised a total of $43.8M across 5 funding rounds to date. The company's 1st funding round was a Private Equity Round of $8.85M, raised on Jun 2005.

Founded in 1989 and based in Paris, France, the company operates in the medical imaging sector. 2D3D orthopedic imaging systems are provided to generate precise skeletal images of patients in upright positions, with reduced radiation exposure. Software solutions are developed to support various aspects of orthopedic care, including diagnostics and treatment planning, for healthcare professionals worldwide.

EOS Iamging's top competitors include OXOS Medical, Aclarion and Scolioscan.

EOS Iamging offers EOSedge, Advanced Orthopedic Solutions, and 3D Modeling.

EOS Iamging has 10 investors. Key investors include Crédit Agricole, ATEC Spine, Fosun Pharmaceutical, Edmond de Rothschild, and IPF Partners.

EOS Iamging operates through Eos Imaging.

Yes. EOS Iamging was acquired by ATEC Spine in February 2020.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available